Tandem Diabetes Care, Inc. TD5A.F Stock
Tandem Diabetes Care, Inc. Price Chart
Tandem Diabetes Care, Inc. TD5A.F Financial and Trading Overview
Tandem Diabetes Care, Inc. stock price | 31.41 EUR |
Previous Close | 24.12 EUR |
Open | 24.4 EUR |
Bid | 24.78 EUR x N/A |
Ask | 24.96 EUR x N/A |
Day's Range | 24.4 - 24.4 EUR |
52 Week Range | 22.36 - 66.9 EUR |
Volume | 10 EUR |
Avg. Volume | 10 EUR |
Market Cap | 1.6B EUR |
Beta (5Y Monthly) | 0.928169 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.2 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 133.5 EUR |
TD5A.F Valuation Measures
Enterprise Value | 1.46B EUR |
Trailing P/E | N/A |
Forward P/E | 32.972973 |
PEG Ratio (5 yr expected) | 0.69 |
Price/Sales (ttm) | 2.0190094 |
Price/Book (mrq) | 4.653824 |
Enterprise Value/Revenue | 1.837 |
Enterprise Value/EBITDA | -18.349 |
Trading Information
Tandem Diabetes Care, Inc. Stock Price History
Beta (5Y Monthly) | 0.928169 |
52-Week Change | -52.28% |
S&P500 52-Week Change | 20.43% |
52 Week High | 66.9 EUR |
52 Week Low | 22.36 EUR |
50-Day Moving Average | 31.37 EUR |
200-Day Moving Average | 40.07 EUR |
TD5A.F Share Statistics
Avg. Volume (3 month) | 10 EUR |
Avg. Daily Volume (10-Days) | 1 EUR |
Shares Outstanding | 64.62M |
Float | 64.19M |
Short Ratio | N/A |
% Held by Insiders | 0.53% |
% Held by Institutions | 104.88% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -25.63% |
Operating Margin (ttm) | -11.78% |
Gross Margin | 50.93% |
EBITDA Margin | -10.0090% |
Management Effectiveness
Return on Assets (ttm) | -5.94% |
Return on Equity (ttm) | -52.50% |
Income Statement
Revenue (ttm) | 794.69M EUR |
Revenue Per Share (ttm) | 12.36 EUR |
Quarterly Revenue Growth (yoy) | -3.69% |
Gross Profit (ttm) | 412.99M EUR |
EBITDA | -79540000 EUR |
Net Income Avi to Common (ttm) | -203752000 EUR |
Diluted EPS (ttm) | -3.16 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 519.59M EUR |
Total Cash Per Share (mrq) | 8.04 EUR |
Total Debt (mrq) | 420.4M EUR |
Total Debt/Equity (mrq) | 124.1 EUR |
Current Ratio (mrq) | 4.428 |
Book Value Per Share (mrq) | 5.243 |
Cash Flow Statement
Operating Cash Flow (ttm) | 18.34M EUR |
Levered Free Cash Flow (ttm) | -33238500 EUR |
Profile of Tandem Diabetes Care, Inc.
Country | Germany |
State | CA |
City | San Diego |
Address | 11075 Roselle Street |
ZIP | 92121 |
Phone | 858 366 6900 |
Website | https://www.tandemdiabetes.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 2600 |
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Q&A For Tandem Diabetes Care, Inc. Stock
What is a current TD5A.F stock price?
Tandem Diabetes Care, Inc. TD5A.F stock price today per share is 31.41 EUR.
How to purchase Tandem Diabetes Care, Inc. stock?
You can buy TD5A.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tandem Diabetes Care, Inc.?
The stock symbol or ticker of Tandem Diabetes Care, Inc. is TD5A.F.
Which industry does the Tandem Diabetes Care, Inc. company belong to?
The Tandem Diabetes Care, Inc. industry is Medical Devices.
How many shares does Tandem Diabetes Care, Inc. have in circulation?
The max supply of Tandem Diabetes Care, Inc. shares is 64.56M.
What is Tandem Diabetes Care, Inc. Price to Earnings Ratio (PE Ratio)?
Tandem Diabetes Care, Inc. PE Ratio is now.
What was Tandem Diabetes Care, Inc. earnings per share over the trailing 12 months (TTM)?
Tandem Diabetes Care, Inc. EPS is -3.2 EUR over the trailing 12 months.
Which sector does the Tandem Diabetes Care, Inc. company belong to?
The Tandem Diabetes Care, Inc. sector is Healthcare.